A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.

Clinical trial NCT07140614 · RECRUITING

Trial details

NCT number: NCT07140614
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Charcot-Marie-Tooth Disease, Type 1A

Start date: 2025-09-30
Primary completion: 2028-02-25
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.